Analysen von James Gordon
| 02.07.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 30.06.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 24.06.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 10.06.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 03.06.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 02.06.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 02.06.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 14.05.25 | GSK Underweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 01.05.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.05.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 30.04.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 28.04.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 22.04.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 01.04.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.03.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.03.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 26.03.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 17.03.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 06.03.25 | Lufthansa Underweight | JP Morgan Chase & Co. | |
| 26.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 19.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 07.02.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 06.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.02.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 03.02.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 30.01.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 15.01.25 | GSK Underweight | JP Morgan Chase & Co. | |
| 15.01.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 06.01.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 11.12.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 09.12.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 12.11.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.11.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 04.11.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 31.10.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 30.10.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 25.10.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 25.10.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 11.10.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 09.10.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 03.10.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 25.09.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 23.09.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 17.09.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 17.09.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 09.09.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.08.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 02.08.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 31.07.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 29.07.24 | GSK Underweight | JP Morgan Chase & Co. | |